We aimed to explore the cardiovascular magnetic resonance (CMR) of Takayasu arteritis (TA) and its cardiovascular complications. CMR was conducted on 37 TA patients and 28 healthy individuals. We evaluated the CMR findings and adverse cardiovascular complications at the time of the CMR (ACCCMR). After 8 to 26 months, the major adverse cardiac and cerebrovascular events (MACCEs) were evaluated. The TA included 25 women (67.6%), aged 36 ± 16 years old, and 28 age- and sex-matched healthy controls. Left ventricular (LV) ejection fraction was significantly lower in the TA group than in the control group (51 ± 9% vs. 58 ± 1.7%; p < 0.001). Aortic mural edema was present in 34 patients (92%) and aortic mural hyperenhancement in 36 (97%). Left ventricular global longitudinal strain (LVGLS) was significantly lower in the TA group (median [interquartile range] = 13.70 [3.27] vs. 18.08 [1.35]; p < 0.001). ACCCMR was seen in 13 TA patients (35.1%), with the most common cardiac complication being myocarditis (16.2%). During a median follow-up of 18 months (8–26 months), nine patients developed MACCEs, of which the most common was cerebrovascular accident in five (13.5%). The LVGLS of the CMR had the strongest association with complications. Myocardial strain values, especially LVGLS, can reveal concurrent and future cardiovascular complications in TA patients.
Background: The coronary artery calcium score (CACS) indicates cardiovascular health. A concern in this regard is the ionizing radiation from computed tomography (CT). Recent studies have tried to introduce low-dose CT techniques to assess CACS. We aimed to investigate the accuracy of iterative reconstruction (IR) and threshold modification while applying low tube voltage in coronary artery calcium imaging. Methods: The study population consisted of 107 patients. Each subject underwent an electrocardiogram-gated CT twice, once with a standard voltage of 120 kVp and then a reduced voltage of 80 kVp. The standard filtered back projection (FBP) reconstruction was applied in both voltages. Considering Hounsfield unit (HU) thresholds other than 130 (150, 170, and 190), CACS was calculated using the FBP-reconstructed 80 kVp images. Moreover, the 80 kVp images were reconstructed utilizing IR at different strength levels. CACS was measured in each set of images. The intraclass correlation coefficient (ICC) was used to compare the CACSs. Results: A 64% reduction in the effective dose was observed in the 80 kVp protocol compared to the 120 kVp protocol. Excellent agreement existed between CACS at high-level (strength level = 5) IR in low-kVp images and the standard CACS protocol in scores ≥ 11 (ICC > 0.9 and p < 0.05). Increasing the threshold density to 190 HU in FBP-reconstructed low-kVp images yielded excellent agreement with the standard protocol in scores ≥ 11 (ICC > 0.9 and p < 0.05) and good agreement in score zero (ICC = 0.84 and p = 0.02). Conclusions: The modification of the density threshold and IR provides an accurate calculation of CACS in low-voltage CT with the potential to decrease patient radiation exposure.
1 January 2026 in Cardiology Research and Practice
Background: Atrioventricular canal defect (AVCD) is a congenital heart disease often associated with genetic changes, with a broad spectrum of anatomical patterns. Aim: We present a novel likely pathogenic variant of MYBPC3 in a proband with AVCD. Methods: A clinical and genetic evaluation was conducted on a one‐year‐old Iranian girl referred to our center with cardiac structural abnormalities and her family. Transthoracic echocardiography (TTE) and cardiac computed tomography (CT) were employed for clinical evaluation, and whole exome sequencing (WES), polymerase chain reaction (PCR), and Sanger sequencing were utilized for genetic analysis. Results: TTE revealed a ventricular and atrial septal defect (ASD), along with pulmonary hypertension (PH). The proband was diagnosed with AVCD through cardiac CT. WES identified a novel heterozygous MYBPC3 (NM_000256.3): c.3747_3748insGG; p.(Ile1250Glyfs∗82). Segregation analysis confirmed the presence of the same variant in the proband’s father, who was diagnosed with hypertrophic cardiomyopathy (HCM). Conclusion: We presented the first case of AVCD associated with a novel MYBPC3 variant, expanding the spectrum of cardiac anomalies linked to MYBPC3 mutations. The findings highlight the complexity and variable expression of MYBPC3 within affected family members.